Research Topic

Idiopathic Intracranial Hypertension

About this Research Topic

Background - Idiopathic intracranial hypertension (IIH) is characterized by raised intracranial pressure without any identifiable pathology in the brain and with normal cerebrospinal fluid (CSF) composition. A typical patient of IIH is an obese woman of childbearing age. Headache is the most common symptom. Papilledema, or optic disc swelling is the main finding. Visual loss, which is the only serious complication, may occur either early or late in the course of the disease. OCT has shown promise for diagnosis and monitoring of patients. The etiology of IIH is still unclear. Recent evidence suggests that it is a disease of metabolic dysregulation. Classical choices of medical treatment are diuretics, particularly acetazolamide or furosemide, and encouragement of weight loss. Medical options, including 11β-Hydroxysteroid Dehydrogenase Type 1 inhibitors are on the way. Treating headaches with monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) signaling pathway is also a recent development. Optic nerve sheath fenestration (ONSF) and CSF diversion procedures are effective surgical treatment modalities. Cerebral venous sinus stenting is an emerging strategy.

Details for authors - The scope of this Research Topic is to make a review of IIH dealing mainly with recent advances in the pathophysiology, patient monitoring and treatment. Subtopics will include:
Clinical features
Underlying mechanisms
Novel advances in monitoring the disease
Current and emerging medical treatments
Surgical treatment options


Keywords: Headache, Papilledema, Diplopia, CSF Pressure, Treatment


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Background - Idiopathic intracranial hypertension (IIH) is characterized by raised intracranial pressure without any identifiable pathology in the brain and with normal cerebrospinal fluid (CSF) composition. A typical patient of IIH is an obese woman of childbearing age. Headache is the most common symptom. Papilledema, or optic disc swelling is the main finding. Visual loss, which is the only serious complication, may occur either early or late in the course of the disease. OCT has shown promise for diagnosis and monitoring of patients. The etiology of IIH is still unclear. Recent evidence suggests that it is a disease of metabolic dysregulation. Classical choices of medical treatment are diuretics, particularly acetazolamide or furosemide, and encouragement of weight loss. Medical options, including 11β-Hydroxysteroid Dehydrogenase Type 1 inhibitors are on the way. Treating headaches with monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) signaling pathway is also a recent development. Optic nerve sheath fenestration (ONSF) and CSF diversion procedures are effective surgical treatment modalities. Cerebral venous sinus stenting is an emerging strategy.

Details for authors - The scope of this Research Topic is to make a review of IIH dealing mainly with recent advances in the pathophysiology, patient monitoring and treatment. Subtopics will include:
Clinical features
Underlying mechanisms
Novel advances in monitoring the disease
Current and emerging medical treatments
Surgical treatment options


Keywords: Headache, Papilledema, Diplopia, CSF Pressure, Treatment


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

30 September 2021 Abstract
06 December 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

30 September 2021 Abstract
06 December 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..